# Farnesol **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/farnesol **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-28 **Evidence Score:** 4 / 10 **Category:** Compound **Also Known As:** 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, (2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-ol, Sesquiterpene alcohol, 15-carbon acyclic sesquiterpene, CAS 4602-84-0, trans-Farnesol ## Overview Farnesol is a natural sesquiterpenoid alcohol found in essential oils of plants such as linden, rose, and citronella, functioning as a farnesyl pyrophosphate-derived isoprenoid in the mevalonate pathway. Research to date has focused almost entirely on its biotechnological and [antimicrobial](/ingredients/condition/immune-support) properties in laboratory and microbial systems, with no documented human clinical trials establishing therapeutic benefits. ## Health Benefits • No clinical health benefits documented - No human clinical trials, RCTs, or meta-analyses on farnesol were identified in the available research • Biotechnological applications only - Current research focuses solely on microbial production and recovery methods (PMID 19569196) • No therapeutic effects established - The provided sources contain no data on health outcomes or therapeutic applications • No safety profile available - No information on contraindications, drug interactions, or maximum safe doses exists in the literature • No traditional medicinal use documented - Sources provide no historical or traditional medicine applications ## Mechanism of Action Farnesol acts as a quorum-sensing molecule that disrupts fungal morphogenesis in Candida albicans by inhibiting the yeast-to-hyphal transition, interfering with Ras1-cAMP-PKA signaling. It also inhibits squalene synthase, a key enzyme in the cholesterol biosynthesis branch of the mevalonate pathway, reducing downstream sterol production. Additionally, farnesol can activate peroxisome proliferator-activated receptor alpha (PPARα) and induce apoptosis in certain cancer cell lines via [mitochondrial](/ingredients/condition/energy) membrane depolarization and [reactive oxygen species](/ingredients/condition/antioxidant) generation, though these effects have only been demonstrated in vitro. ## Clinical Summary No human clinical trials, randomized controlled trials, or meta-analyses on farnesol supplementation have been identified in the published literature as of the available research base. Existing research is limited to in vitro cell studies, animal models, and biotechnological investigations into microbial production and recovery methods (PMID 19569196). Animal studies have demonstrated antitumor and [antimicrobial](/ingredients/condition/immune-support) effects at micromolar concentrations, but these findings have not been translated into human trials. The overall evidence base is insufficient to support any clinical health claims, and farnesol remains an investigational compound without established therapeutic dosing in humans. ## Nutritional Profile Farnesol (C15H26O) is a sesquiterpene alcohol with molecular weight of 222.37 g/mol, not a nutritional ingredient and therefore carries no macronutrient, micronutrient, vitamin, mineral, fiber, or protein content. It is a naturally occurring acyclic diterpene alcohol found endogenously in many essential oils including rose, lemon grass, tuberose, and citronella at trace concentrations (typically 0.1–2% of essential oil composition). As a pure bioactive compound, it exists as a colorless liquid with a mild floral odor. Bioactive compound profile: farnesol is a isoprenoid/terpenoid belonging to the sesquiterpene class; it occurs in two primary geometric isomers (trans,trans-farnesol being the most biologically active). It is a precursor in cholesterol and sterol biosynthesis pathways (mevalonate pathway intermediate). Endogenous concentrations in human serum are not well-characterized in clinical literature. Bioavailability is limited by its lipophilic nature (logP approximately 4.5), poor water solubility (~0.01 mg/mL), and rapid [metabolism](/ingredients/condition/weight-management) via oxidation to farnesal and farnesoic acid. It is not consumed as a food nutrient; exposure occurs primarily via cosmetic/fragrance products (regulated as a potential allergen in EU at >0.001% in leave-on products) or as a minor constituent of plant-derived foods at sub-microgram per gram concentrations. ## Dosage & Preparation No clinically studied dosage ranges, forms, or standardization details are available as no human clinical data exists. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Farnesol is generally recognized as safe (GRAS) by the FDA as a flavoring agent at very low dietary exposure levels, but safety data for supplemental doses in humans is essentially absent. As a potent inhibitor of squalene synthase and modulator of the mevalonate pathway, theoretical interactions exist with statins and other cholesterol-lowering drugs, though no clinical interaction studies have been conducted. Farnesol has demonstrated cytotoxic effects in cell culture at higher concentrations, raising theoretical concerns about toxicity at supplemental doses. Pregnancy and lactation safety is entirely unknown, and use should be avoided in these populations in the absence of safety data. ## Scientific Research No human clinical trials, randomized controlled trials, or meta-analyses on farnesol were identified in the available sources. The only referenced study (PMID 19569196) describes biotechnological processes for farnesol production using yeast erg9 mutant cultures, achieving 99% purity post-chromatography, but this represents production methodology rather than clinical research. ## Historical & Cultural Context No historical or traditional medicinal uses in any systems are mentioned in the available research sources. The compound appears to be studied primarily for its industrial and biotechnological applications rather than therapeutic purposes. ## Synergistic Combinations No synergistic ingredients identified due to lack of clinical research ## Frequently Asked Questions ### Does farnesol have any proven health benefits in humans? No human clinical trials have documented health benefits of farnesol supplementation. All mechanistic research—including antimicrobial, antitumor, and cholesterol-related effects—has been conducted exclusively in cell cultures or animal models, meaning no therapeutic claims can be substantiated for humans at this time. ### What foods or plants naturally contain farnesol? Farnesol occurs naturally in the essential oils of linden blossoms, rose, citronella, neroli, cyclamen, tuberose, and chamomile, typically at concentrations below 1% of the oil. Dietary exposure through these plant sources is extremely low and unlikely to produce pharmacological effects at normal consumption levels. ### How does farnesol work against Candida and fungal infections? Farnesol functions as a quorum-sensing molecule in Candida albicans, inhibiting the morphological switch from the yeast form to the more pathogenic hyphal form by suppressing the Ras1-cAMP-PKA signaling pathway. This mechanism has been demonstrated in vitro at concentrations of 50–300 micromolar, but no clinical studies have tested farnesol as an antifungal treatment in humans. ### Is farnesol the same as farnesene or farnesyl pyrophosphate? No, these are related but distinct isoprenoid compounds. Farnesol (C15H26O) is the alcohol form, farnesene is an unsaturated hydrocarbon isomer, and farnesyl pyrophosphate (FPP) is the activated biosynthetic precursor in the mevalonate pathway from which farnesol, cholesterol, and other terpenoids are derived. Farnesol is produced by dephosphorylation of FPP and serves as a feedback regulator of the pathway. ### What is the current research focus for farnesol? Current research on farnesol is concentrated primarily in biotechnology, specifically optimizing microbial fermentation and recovery methods to produce farnesol at industrial scale using engineered yeast strains (PMID 19569196). Secondary research areas include its in vitro cytotoxic effects on cancer cell lines via mitochondrial apoptosis pathways and its role as a quorum-sensing inhibitor in biofilm disruption, but neither area has advanced to human clinical investigation. ### Is farnesol safe for use in supplements and cosmetics? Farnesol is generally recognized as safe (GRAS) by the FDA for use in cosmetics and personal care products, where it functions as a preservative and fragrance ingredient. However, no human safety studies or toxicology data from clinical trials exist to establish safe supplemental dosages or long-term internal use. Its safety profile is based primarily on historical use in topical applications rather than oral supplementation or systemic health claims. ### Why is farnesol mainly used in industrial and cosmetic applications rather than as a health supplement? Farnesol's commercial applications are limited to biotechnological production and cosmetic formulations because no human clinical evidence supports therapeutic health benefits. The current research focus remains on optimizing microbial fermentation and extraction methods for industrial-scale production rather than investigating human health outcomes. Without demonstrated clinical efficacy in humans, it lacks the scientific foundation required for marketing as a therapeutic supplement. ### What is the difference between farnesol in cosmetics versus potential therapeutic use? In cosmetics and personal care, farnesol serves as a natural preservative and fragrance component with an established safety history in topical formulations. As a potential therapeutic agent, farnesol would require human clinical trials to demonstrate efficacy and establish safe dosing—evidence that currently does not exist. The compound's antimicrobial properties shown in laboratory studies have not translated into proven health applications or approved therapeutic uses in humans. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*